Cargando…

Risperidone Related Raynaud’s Phenomenon: An Adolescent Case

Raynaud’s phenomenon is a recurrent vasospastic condition with reducing in peripheral blood flow due to cold, or emotional stress. White, blue and red discolorations occur during the attacks. Serotonin reuptake inhibitors, psychostimulants, and aripiprazole are reported to be related with Raynaud’s...

Descripción completa

Detalles Bibliográficos
Autores principales: Güneş, Serkan, Ekinci, Özalp, Teke, Halenur, Yıldırım, Veli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810444/
https://www.ncbi.nlm.nih.gov/pubmed/29397675
http://dx.doi.org/10.9758/cpn.2018.16.1.118
_version_ 1783299755611258880
author Güneş, Serkan
Ekinci, Özalp
Teke, Halenur
Yıldırım, Veli
author_facet Güneş, Serkan
Ekinci, Özalp
Teke, Halenur
Yıldırım, Veli
author_sort Güneş, Serkan
collection PubMed
description Raynaud’s phenomenon is a recurrent vasospastic condition with reducing in peripheral blood flow due to cold, or emotional stress. White, blue and red discolorations occur during the attacks. Serotonin reuptake inhibitors, psychostimulants, and aripiprazole are reported to be related with Raynaud’s phenomenon. Risperidone is an atypical antipsychotic drug with dopaminergic and serotonergic effects. In children and adolescents, risperidone is used for bipolar disorder, tic disorders, conduct disorder, schizophrenia, symptoms of irritability and self-mutilation. Here we report a case of Raynaud’s phenomenon associated with risperidone in a 12-year-old boy. Raynaud’s phenomenon occurred two weeks after starting risperidone and disappeared after stopping risperidone.
format Online
Article
Text
id pubmed-5810444
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Korean College of Neuropsychopharmacology
record_format MEDLINE/PubMed
spelling pubmed-58104442018-02-21 Risperidone Related Raynaud’s Phenomenon: An Adolescent Case Güneş, Serkan Ekinci, Özalp Teke, Halenur Yıldırım, Veli Clin Psychopharmacol Neurosci Case Report Raynaud’s phenomenon is a recurrent vasospastic condition with reducing in peripheral blood flow due to cold, or emotional stress. White, blue and red discolorations occur during the attacks. Serotonin reuptake inhibitors, psychostimulants, and aripiprazole are reported to be related with Raynaud’s phenomenon. Risperidone is an atypical antipsychotic drug with dopaminergic and serotonergic effects. In children and adolescents, risperidone is used for bipolar disorder, tic disorders, conduct disorder, schizophrenia, symptoms of irritability and self-mutilation. Here we report a case of Raynaud’s phenomenon associated with risperidone in a 12-year-old boy. Raynaud’s phenomenon occurred two weeks after starting risperidone and disappeared after stopping risperidone. Korean College of Neuropsychopharmacology 2018-02 2018-02-28 /pmc/articles/PMC5810444/ /pubmed/29397675 http://dx.doi.org/10.9758/cpn.2018.16.1.118 Text en Copyright © 2018, Korean College of Neuropsychopharmacology This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Güneş, Serkan
Ekinci, Özalp
Teke, Halenur
Yıldırım, Veli
Risperidone Related Raynaud’s Phenomenon: An Adolescent Case
title Risperidone Related Raynaud’s Phenomenon: An Adolescent Case
title_full Risperidone Related Raynaud’s Phenomenon: An Adolescent Case
title_fullStr Risperidone Related Raynaud’s Phenomenon: An Adolescent Case
title_full_unstemmed Risperidone Related Raynaud’s Phenomenon: An Adolescent Case
title_short Risperidone Related Raynaud’s Phenomenon: An Adolescent Case
title_sort risperidone related raynaud’s phenomenon: an adolescent case
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810444/
https://www.ncbi.nlm.nih.gov/pubmed/29397675
http://dx.doi.org/10.9758/cpn.2018.16.1.118
work_keys_str_mv AT gunesserkan risperidonerelatedraynaudsphenomenonanadolescentcase
AT ekinciozalp risperidonerelatedraynaudsphenomenonanadolescentcase
AT tekehalenur risperidonerelatedraynaudsphenomenonanadolescentcase
AT yıldırımveli risperidonerelatedraynaudsphenomenonanadolescentcase